TCG Crossover GP II, LLC 13D/13G Filings for Amylyx Pharmaceuticals, Inc. (AMLX)

TCG Crossover GP II, LLC 13D and 13G filings for Amylyx Pharmaceuticals, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2024-08-26
6:49 pm
Purchase		 2024-08-14 13G Amylyx Pharmaceuticals, Inc.
AMLX		 TCG Crossover GP II, LLC 4,643,812
6.800%		 4,643,812increase
(New Position)		 Filing